Glucose tolerance and serum lipids in man after long-term lithium administration.
Intravenous glucose tolerance and serum lactate concentration during the tolerance test were determined in the same 12 patients after 6 months of placebo and after 6 months of lithium treatment. At the end of these periods values of glucose, lactate, serum free fatty acids, and serum triglycerides were measured in fasting patients. Long-term lithium treatment had no influence on these parameters.
D001786:Blood Glucose / Q000032:analysis; D050260:Carbohydrate Metabolism; D002986:Clinical Trials as Topic; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007773:Lactates / Q000097:blood; D008055:Lipids / Q000097:blood*; D008094:Lithium / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008575:Meniere Disease / Q000097:blood* / Q000188:drug therapy; D010919:Placebos; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D008055:Lipids; D010919:Placebos; D014280:Triglycerides; D008094:Lithium